Axon workstation wins R&D award
Thursday, 31 July, 2003
ASX-listed Axon Instruments has picked up an R&D 100 award for its OpusExpress 6000A electrophysiology workstation.
The awards, which recognise the 100 most innovative new technologies of the previous 12 months, is made by the editors of R&D Magazine and a panel of independent judges.
Axon's OpusExpress system is described by the company as the first commercially available multi-channel, automated oocyte voltage-clamp recording system, which makes possible high-throughput electrophysiology and improves the efficiency of the drug discovery process.
In a statement, Axon CEO Alan Finkel said high-throughput electrophysiology was the wave of the future.
"It is changing the way that pharmaceutical companies search for ion-channel drugs," Finkel said.
Ion channels have been implicated in a number of diseases, including cystic fybrosis, epilepsy, muscular dystrophy, migraine and cancer. The Human Genome project identified between 300 and 400 ion-channel genes in humans.
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
Life expectancy gains are slowing, study finds
Life expectancy at birth in the world's longest-living populations has increased by an...
Towards safer epilepsy treatment for pregnant women
New research conducted in organoids is expected to provide pregnant women with epilepsy safer...
